1. Deferiprone was associated with an increase in MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores compared to placebo, indicating worsening ...
1. In comparison to placebo, ENT-01 increased rates of complete spontaneous bowel movements per week for patients with Parkinson's disease ...
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were ...
1. Inpatient or outpatient clinic diagnosed influenza infection was associated with an increased odds ratio of diagnosis with Parkinson Disease ...
1. During an 80-week trial period of patient’s with early Parkinson’s disease (PD), there was no difference in the severity ...
1. In this phase-2 randomized controlled trial, high-intensity treadmill exercise was associated with lower mean changes in the Unified Parkinson’s ...
1. Creatine monohydrate was not shown to improve or worsen clinical outcomes of Parkinson disease over a 5-year follow-up period. ...
1. Diffusion tensor imaging (DTI) of marmoset brains following chemically-induced Parkinsonism showed an increase in nigrostriatial diffusivity with a loss ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Association ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.